Cargando…

E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma

E2F transcriptional factors are widely expressed in a number of tissues and organs, possessing many regulatory functions related to cellular proliferation, differentiation, DNA repair, cell-cycle and cell apoptosis. E2F8 is a recently identified member of the E2F family with a duplicated DNA-binding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Yi, Xiao, Jia, Liu, Jing, Xing, Feiyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463435/ https://www.ncbi.nlm.nih.gov/pubmed/28607595 http://dx.doi.org/10.7150/jca.18255

Ejemplares similares

Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report
por: Lü, Ying, et al.
Publicado: (2020)

Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
por: Luo, Xiang-Yuan, et al.
Publicado: (2021)

Nosip is a potential therapeutic target in hepatocellular carcinoma cells
por: Gao, Junjie, et al.
Publicado: (2023)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma
por: Tan, Zhibo, et al.
Publicado: (2022)

Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer
por: Liu, Xuhong, et al.
Publicado: (2020)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
por: Loong, Herbert H, et al.
Publicado: (2014)

Sgo1 is a potential therapeutic target for hepatocellular carcinoma
por: Wang, Lyu-Han, et al.
Publicado: (2015)

Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma
por: Kiruthiga, Chandramohan, et al.
Publicado: (2020)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma
por: Zhang, Junyong, et al.
Publicado: (2016)

Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma
por: Sun, Cheng-Cao, et al.
Publicado: (2018)

A Panel of E2F Target Gene Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Hu, Wenmin, et al.
Publicado: (2022)

Nogo‐B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma
por: Cai, Hao, et al.
Publicado: (2018)

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
por: Yang, Heng, et al.
Publicado: (2021)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment
por: Wang, Jukun, et al.
Publicado: (2021)

Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
por: Zheng, Jing, et al.
Publicado: (2023)

The E2F family as potential biomarkers and therapeutic targets in colon cancer
por: Yao, Haibo, et al.
Publicado: (2020)

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
por: Xian, Jingrong, et al.
Publicado: (2022)

KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
por: Gao, Chao, et al.
Publicado: (2022)

DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism
por: Li, Guangtao, et al.
Publicado: (2022)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
por: Zhou, Dong-Sheng, et al.
Publicado: (2015)

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
por: Tsirulnikov, Kirill, et al.
Publicado: (2018)

Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma
por: Liao, Haotian, et al.
Publicado: (2019)

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma
por: Awad, Abeer E., et al.
Publicado: (2019)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects
por: Xiao, Zhangang, et al.
Publicado: (2018)

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
por: Ouyang, Xiaoxi, et al.
Publicado: (2022)

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target
por: Hung, Chao-Hung, et al.
Publicado: (2014)

DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma
por: Shi, Min, et al.
Publicado: (2017)

Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
por: Schulze, Kornelius, et al.
Publicado: (2015)

KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma
por: Fu, Xiaowei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r08jceeise35jsubkd14qia0ao